Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine decreases stereotypic behavior in primates.

Charmaine Hugo1, Jurgen Seier, Chris Mdhluli

  • 1Medical Research Council (MRC) Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, Tygerberg, South Africa. cjhugo@sun.ac.za

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|June 6, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memoriam: Professor Dan J. Stein (1962-2025) - A Global Pioneer with an African Heart.

The international journal of neuropsychopharmacology·2025
Same author

The Zebrafish Neurobehavioral Catalog-Volume 2 (New Addition).

Zebrafish·2025
Same author

Neuro-Inflammatory and Behavioral Changes Are Selectively Reversed by <i>Sceletium tortuosum</i> (Zembrin<sup>®</sup>) and Mesembrine in Male Rats Subjected to Unpredictable Chronic Mild Stress.

Cells·2025
Same author

The efficacy of adjunctive <i>Garcinia mangostana</i> Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial.

The British journal of psychiatry : the journal of mental science·2025
Same author

A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Etorphine induces pathophysiology in immobilized white rhinoceros through sympathomimesis that is attenuated by butorphanol.

Conservation physiology·2025

Captive primates exhibiting stereotypic behaviors showed improvement with fluoxetine, a selective serotonin reuptake inhibitor (SSRI). This study suggests SSRIs may help manage these behaviors in animals, similar to human anxiety treatments.

Area of Science:

  • Primate behavior
  • Neuroscience
  • Veterinary psychiatry

Background:

  • Captive primates can develop stereotypic behaviors.
  • These behaviors resemble human obsessive-compulsive or posttraumatic symptoms.
  • Selective serotonin reuptake inhibitors (SSRIs) are used to treat human anxiety disorders.

Purpose of the Study:

  • To investigate the efficacy of fluoxetine, an SSRI, in reducing stereotypic behaviors in captive vervet monkeys.
  • To explore the parallels between animal stereotypies and human psychiatric conditions.

Main Methods:

  • Ten vervet monkeys with stereotypic behaviors were selected.
  • Subjects were randomly assigned to receive fluoxetine (1 mg/kg) or no treatment for six weeks.
  • A blinded rater assessed the frequency of stereotypic behaviors.

Related Experiment Videos

Main Results:

  • Fluoxetine treatment significantly reduced stereotypic symptoms compared to the control group.
  • Three out of five fluoxetine-treated monkeys responded to treatment, as indicated by Clinical Global Impressions scores.
  • No improvement was observed in the no-treatment group.

Conclusions:

  • Fluoxetine administration led to a gradual and partial decrease in stereotypic behaviors in captive vervets.
  • These findings parallel research on SSRI efficacy for human anxiety symptoms.
  • Further research could inform veterinary care and the neurobiology of psychiatric disorders.